These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22611468)

  • 1. Angiotensin II-inhibition: effect on Alzheimer's pathology in the aged triple transgenic mouse.
    Ferrington L; Palmer LE; Love S; Horsburgh KJ; Kelly PA; Kehoe PG
    Am J Transl Res; 2012; 4(2):151-64. PubMed ID: 22611468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II-inhibiting drugs have no effect on intraneuronal Aβ or oligomeric Aβ levels in a triple transgenic mouse model of Alzheimer's disease.
    Ferrington L; Miners JS; Palmer LE; Bond SM; Povey JE; Kelly PA; Love S; Horsburgh KJ; Kehoe PG
    Am J Transl Res; 2011 Feb; 3(2):197-208. PubMed ID: 21416061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology.
    Kehoe PG; Wong S; Al Mulhim N; Palmer LE; Miners JS
    Alzheimers Res Ther; 2016 Nov; 8(1):50. PubMed ID: 27884212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease.
    Halagappa VK; Guo Z; Pearson M; Matsuoka Y; Cutler RG; Laferla FM; Mattson MP
    Neurobiol Dis; 2007 Apr; 26(1):212-20. PubMed ID: 17306982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical dose of angiotensin-converting enzyme (ACE) inhibitor and heterozygous ACE deletion exacerbate Alzheimer's disease pathology in mice.
    Liu S; Ando F; Fujita Y; Liu J; Maeda T; Shen X; Kikuchi K; Matsumoto A; Yokomori M; Tanabe-Fujimura C; Shimokata H; Michikawa M; Komano H; Zou K
    J Biol Chem; 2019 Jun; 294(25):9760-9770. PubMed ID: 31072831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin IV Receptors Mediate the Cognitive and Cerebrovascular Benefits of Losartan in a Mouse Model of Alzheimer's Disease.
    Royea J; Zhang L; Tong XK; Hamel E
    J Neurosci; 2017 May; 37(22):5562-5573. PubMed ID: 28476949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 9R, the cholinesterase and amyloid beta aggregation dual inhibitor, as a multifunctional agent to improve cognitive deficit and neuropathology in the triple-transgenic Alzheimer's disease mouse model.
    Ju Y; Tam KY
    Neuropharmacology; 2020 Dec; 181():108354. PubMed ID: 33035533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
    Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-β42 Burden in Alzheimer's Disease.
    Rocha NP; Toledo A; Corgosinho LTS; de Souza LC; Guimarães HC; Resende EPF; Braz NFT; Gomes KB; Simoes E Silva AC; Caramelli P; Teixeira AL
    J Alzheimers Dis; 2018; 64(4):1085-1090. PubMed ID: 30040721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related reduction in brain ACE-2 is not exacerbated by Alzheimer's disease pathology in mouse models of Alzheimer's disease.
    MacLachlan R; Evans CE; Chai SY; Good MA; Kehoe PG; Miners JS
    Aging Brain; 2023; 3():100062. PubMed ID: 36911263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal Administration of Monoclonal Antibody Against Pathologic Aβ42 Aggregates Alleviated Cognitive Deficits and Synaptic Lesions in APP/PS1 Mice.
    Xiao S; Song LL; Li JT; Wang H; Yu N; Wang ZQ; Zhang Y; He JS; Hung T
    J Alzheimers Dis; 2020; 73(2):657-670. PubMed ID: 31839610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age Related Changes in Muscle Mass and Force Generation in the Triple Transgenic (3xTgAD) Mouse Model of Alzheimer's Disease.
    Xu H; Bhaskaran S; Piekarz KM; Ranjit R; Bian J; Kneis P; Ellis A; Bhandari S; Rice HC; Van Remmen H
    Front Aging Neurosci; 2022; 14():876816. PubMed ID: 35547624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related changes in core body temperature and activity in triple-transgenic Alzheimer's disease (3xTgAD) mice.
    Knight EM; Brown TM; Gümüsgöz S; Smith JC; Waters EJ; Allan SM; Lawrence CB
    Dis Model Mech; 2013 Jan; 6(1):160-70. PubMed ID: 22864021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of Aβ43 to Aβ40 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme.
    Liu S; Liu J; Miura Y; Tanabe C; Maeda T; Terayama Y; Turner AJ; Zou K; Komano H
    J Neurosci Res; 2014 Sep; 92(9):1178-86. PubMed ID: 24823497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aβ-accelerated neurodegeneration caused by Alzheimer's-associated
    Cuddy LK; Prokopenko D; Cunningham EP; Brimberry R; Song P; Kirchner R; Chapman BA; Hofmann O; Hide W; Procissi D; Hanania T; Leiser SC; Tanzi RE; Vassar R
    Sci Transl Med; 2020 Sep; 12(563):. PubMed ID: 32998969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer's disease model.
    Ongali B; Nicolakakis N; Tong XK; Aboulkassim T; Papadopoulos P; Rosa-Neto P; Lecrux C; Imboden H; Hamel E
    Neurobiol Dis; 2014 Aug; 68():126-36. PubMed ID: 24807206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in amyloid-β and Tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein.
    Maia LF; Kaeser SA; Reichwald J; Hruscha M; Martus P; Staufenbiel M; Jucker M
    Sci Transl Med; 2013 Jul; 5(194):194re2. PubMed ID: 23863834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-Onset Network Hyperexcitability in Presymptomatic Alzheimer's Disease Transgenic Mice Is Suppressed by Passive Immunization with Anti-Human APP/Aβ Antibody and by mGluR5 Blockade.
    Kazim SF; Chuang SC; Zhao W; Wong RK; Bianchi R; Iqbal K
    Front Aging Neurosci; 2017; 9():71. PubMed ID: 28392767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau passive immunization inhibits not only tau but also Aβ pathology.
    Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
    Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.